Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes
- PMID: 24529565
- DOI: 10.1016/j.diabres.2013.12.018
Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes
Abstract
Aims: To investigate early alterations on bone mineral density (BMD) and RANK, RANKL and OPG mRNA expression in peripheral blood leukocytes (PBL) in children and adolescents with type 1 diabetes (T1D) and the relationship with glycemic control and bone biomarkers.
Methods: This cross-sectional study included 75 children and adolescents with T1D and 100 individuals without diabetes (normoglycemic-NG) aged 6-20 years old. T1D individuals were considered to have good (T1DG) or poor (T1DP) glycemic control according to the values of HbA1c. Phosphorus, magnesium, total and ionized calcium, osteocalcin, alkaline phosphatase and tartaric-resistant acid phosphatase (TRAP) values were determined in blood samples. BMD was measured by DEXA. RANK, RANKL and OPG mRNA expression was measured in PBL by real-time PCR.
Results: Osteocalcin values were decreased in diabetic groups in comparison to NG group (p<0.05), and a negative correlation with both serum glucose (r=-0.265, p<0.01) and Hb1Ac (r=-0.252, p<0.01) in T1D group was found. BMD was lower in diabetic groups in comparison with NG group (p<0.05) and a negative correlation was observed between BMD and both serum glucose (r=-0.357, p<0.01) and HbA1c (r=-0.351, p<0.01) in T1D group. OPG mRNA expression was significantly increased in T1D and T1DP groups in comparison with NG group (p<0.05). In conclusion, children and adolescents with early onset T1D presented low bone mineral density associated to unsatisfactory glycemic control, increased OPG mRNA expression and low osteocalcin concentration.
Keywords: Bone metabolism; Diabetic osteopathy; OPG expression; Type 1 diabetes.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Bone accrual in children and adolescents with type 1 diabetes: current knowledge and future directions.Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1;28(4):340-347. doi: 10.1097/MED.0000000000000638. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33965967 Review.
-
OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.Ital J Pediatr. 2019 Dec 10;45(1):161. doi: 10.1186/s13052-019-0748-1. Ital J Pediatr. 2019. PMID: 31823791 Free PMC article.
-
Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.Osteoporos Int. 2016 Apr;27(4):1631-1643. doi: 10.1007/s00198-015-3422-5. Epub 2015 Nov 20. Osteoporos Int. 2016. PMID: 26588909
-
Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.J Endocrinol Invest. 2015 Sep;38(9):941-50. doi: 10.1007/s40618-015-0284-9. Epub 2015 Apr 12. J Endocrinol Invest. 2015. PMID: 25863666 Review.
-
Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.Menopause. 2007 Sep-Oct;14(5):913-8. doi: 10.1097/gme.0b013e31802d976f. Menopause. 2007. PMID: 17667143
Cited by
-
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.Sci Adv. 2023 Nov 3;9(44):eadf5238. doi: 10.1126/sciadv.adf5238. Epub 2023 Nov 1. Sci Adv. 2023. PMID: 37910614 Free PMC article.
-
Relationship between risk factors for impaired bone health and HR-pQCT in young adults with type 1 diabetes.Front Endocrinol (Lausanne). 2023 Mar 3;14:1144137. doi: 10.3389/fendo.2023.1144137. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36936151 Free PMC article.
-
Osteocalcin serum concentrations and markers of energetic metabolism in pediatric patients. Systematic review and metanalysis.Front Pediatr. 2023 Jan 12;10:1075738. doi: 10.3389/fped.2022.1075738. eCollection 2022. Front Pediatr. 2023. PMID: 36714656 Free PMC article. Review.
-
A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually.Bone. 2022 Dec;165:116559. doi: 10.1016/j.bone.2022.116559. Epub 2022 Sep 15. Bone. 2022. PMID: 36116758 Free PMC article.
-
Biochemical Markers of Bone Turnover in Older Adults With Type 1 Diabetes.J Clin Endocrinol Metab. 2022 May 17;107(6):e2405-e2416. doi: 10.1210/clinem/dgac099. J Clin Endocrinol Metab. 2022. PMID: 35188961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical